Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Regulatory & Legal View source PDF Explain this filing

CARERATING · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹1690.00

prior close

₹1672.50

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%-1.2% vs market

Capital Markets peers, median of 61sector · industry level-0.6%-0.9% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.9 pts less than its Capital Markets peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.3

15m

-0.4

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5-0.4-1.2-0.6-0.9

Next day

+0.5+1.1-0.6-0.3+0.8

-1.4+1.0-2.4+0.2-1.6

-1.6+2.6-4.3+1.0-2.7

-2.4+4.2-6.7+2.2-4.6

-2.5+4.2-6.6+1.3-3.8

-6.9-0.5-6.4-1.7-5.1

15d

+2.3+0.9+1.4-1.5+3.9

-5.2+1.5-6.7-3.0-2.2

-2.3+9.1-11.4-1.4-0.8

+1.0+8.1-7.1-0.8+1.7

UpDownMarket · Nifty Microcap 250Sector · Capital Markets peers, median of 61Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CARE Ratings Limited has received SEBI authorisation to begin providing services as a Past Risk and Return Verification Agency (PaRRVA) from May 4, 2026. The company had initially received recognition for this role in December 2025 and successfully completed a pilot phase. This authorisation allows CARE Ratings to offer PaRRVA services as per SEBI's April 29, 2026 circular. The company has been operational since 1993 and is listed on both BSE and NSE.

Likely market impact

This represents a new revenue stream for CARE Ratings, expanding its service offerings beyond traditional credit ratings. The SEBI authorisation validates the company's capability and could positively impact investor sentiment.